Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 464

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 464
---
 ended December31, 2026. The Business Combination is expected to be accounted for as a reverse capitalization in accordance with GAAP. We expect to be deemed the accounting predecessor of the combined business, and New Profusa, Inc. (“New Profusa”) as the parent company of the combined business, will be the successor SEC registrant, meaning that our financial statements for previous periods will be disclosed in the registrant’s future periodic reports filed with the SEC. The Business Combination is expected to have a significant impact on our future capital structure and operating results, de -riskingour product development, manufacturing and commercialization. The most significant changes in New Profusa’s future reported financial positions are expected to be an estimated net increase in cash (as compared to our balance sheet at December31, 2024) of between approximately $13.0 million, assuming maximum shareholder redemptions permitted under the Merger Agreement, and $14.9 million, assuming no shareholder redemptions, including approximately $9.0 million in proceeds from the PIPE Investment to be consummated substantially simultaneously with the Business Combination. As the purchase of the Initial Note will be the only portion of the PIPE that is funded as of the Closing Date of the Business Combination, and the likelihood of the remaining PIPE Convertible Notes cannot be determined, only the Initial Note and related purchase price are reflected in the unaudited pro forma financial. See section entitled “ Unaudited Pro Forma Condensed Combined Balance Sheet As Of December 31, 2024” for additional information. Each redemption scenario includes $6.6 million remaining in cash -basedtransaction costs for the Business Combination, which includes $2.0 million related to the underwriters marketing fee related to NorthView IPO, which is payable upon a successful consummation of the Business Combination. See “ Unaudited Pro Forma Condens ed Combined Financial Information.” In June 2023, the Company entered into a short -termloan agreement with a related party under which it may borrow up to $1.6 million, of which $1.0 million was borrowed on June 26, 2023, $0.3 million was borrowed on July 20, 2023, $0.3 million was borrowed on August 15, 2023 (the “Tasly Convertible Debt”). An additional amount of less than $0.02 million was drawn on February 6, 2024. The loans bear interest at a rate of 12% per annum